Solexa
Solexa engages in developing and commercializing genetic analysis technologies primarily in the United States and the United Kingdom. The company is developing and preparing Solexa Genome Analysis System, which performs DNA sequencing based on its proprietary reversible terminator Sequencing-by-Synthesis, chemistry, and Clonal Single Molecule Array technology. Its platform is designed to support a range of analyses, including whole genome resequencing, gene expression analysis, and small RNA analysis.
View Top Employees for Solexa
|
Industry | Biotechnology |
|
Location | United States |
|
Employees | 14 |
|
HQ | 25861 Industrial Boulevard |
|
Funding | 222,900,000 USD |
|
Competitors | Roche, Agilent Technologies, Amgen, Genentech, Eurofins, Gilead Sciences, |
|
|
Industry | Biotechnology |
|
|
Location | United States |
|
|
Employees | 14 |
|
linkedin.com/company/solexa | |
|
|
HQ | 25861 Industrial Boulevard |
|
|
Funding | 222,900,000 USD |
Top Competitors for Solexa
Solexa Questions
Where are Solexa's headquarters?
Solexa's headquarters are in 25861 Industrial Boulevard
How many employees are working in Solexa right now?
Solexa has
14 employees.
View the Email and Phone Numbers for all 14 working at Solexa.
What is Solexa's industry?
Solexa's industry is
Biotechnology
Who are Solexa's top competitors?
Solexa's top competitors are
Roche
,
Agilent Technologies
,
Amgen
,
Genentech
,
Eurofins
,
Gilead Sciences
What are Solexa's categories?
Solexa's categories are Biotechnology, Genetics, Medical, Medical Device
What is Solexa's location?
Solexa's location is
United States
What is Solexa's funding?
Solexa's funding is 222,900,000 USD
What is Solexa's current status?
Solexa's current status is acquired
